Influence of pharmacogenomic polymorphisms on allopurinol-induced cutaneous adverse drug reactions in Thai patients

• Principais autores: Gaidganok Sornsamdang (Autor), Patompong Satapornpong (Autor), Pimonpan Jinda (Autor), Thawinee Jantararoungtong (Autor), Napatrupron Koomdee (Autor), Therdpong Tempark (Autor), Jettanong Klaewsongkram (Autor), Ticha Rerkpattanapipat (Autor), Pawinee Rerknimitr (Autor), Papapit Tuchinda (Autor), Leena Chularojanamontri (Autor), Napatra Tovanabutra (Autor), Kumutnart Chanprapaph (Autor), Wareeporn Disphanurat (Autor), Panlop Chakkavittumrong (Autor), Chutika Srisuttiyakorn (Autor), Yuttana Srinoulprasert (Autor), Shobana John (Autor), Mohitosh Biswas (Autor), Chonlaphat Sukasem (Autor)
• Formato: Livro
• Publicado em: BMC, 2024-04-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Background Allopurinol has been causing substantial morbidity and mortality particularly in Asian population by producing cutaneous adverse drug reactions (cADRs). Nonetheless, there are no data describing whether other genetics are a valid marker for prediction of allopurinol-induced cADRs...